Evidence map›Paper›PMID 35360116›Full record

ReviewFrontiers in cellular and infection microbiology2022

Difference Analysis Between Canine Adenovirus Types 1 And 2.

Yanzhu Zhu, Jinfeng Xu, Shizhen Lian, Rui Zhang, Jinyu Hou, Minchun Wang, Xijun Yan

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Immunological evaluation of recombination PRRSV GP3 and GP5 DNA vaccinesFrontiers in cellular and infection microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yanzhu ZhuInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.
Jinfeng XuInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.
Shizhen LianInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.
Rui ZhangInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.
Jinyu HouCollege of Traditional Chinese Medicine, Jilin Agricultural University, Changchun, China.
Minchun WangInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.
Xijun YanInstitute of Special Animal and Plant Sciences of Chinese Academy of Agricultural Sciences, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canine adenoviruses (CAdVs) include type 1 (CAdV-1, virulent strain) and type 2 (CAdV-2, attenuated strain). In recent years, the incidences of CAdV infections are increasing. However, they are difficult to distinguish when the symptoms are untypical. It is pivotal to find the differences between the two virus types for scientific, epidemiological, and specific treatment. CAdV-1 (virulent strain) and CAdV-2 (attenuated strain) induced canine hepatitis (ICH) and tracheobronchitis (ITB), respectively, but the clinical symptom is not obvious. CAdV-1 and CAdV-2 have the same genome structure, diameter, morphological features, and cytopathic features, but the same character hinder the diagnose time of the serotypes. CAdV-1 and CAdV-2 have a difference in the genome sequence, coding proteins, viral activity, hemagglutination patterns. After infection, pathogenicity and transmission route are different between the two serotypes. Sequence alignment, PCR, Real time-PCR assay are useful methods to distinguish the two serotypes. The attenuated live CAdV-2 vaccine is currently used to protect against CAdV-1, but it also has a risk. The further research should focus on the pathogenicity mechanism and the useful vaccine for the two serotypes of canine adenovirus.

Indexed as

Adenoviruses, CanineAnimalsDogsReal-Time Polymerase Chain Reactioncanine adenovirus 1canine adenovirus 2distinguishing methodsinfection characteristicsvirus genome

Identifiers

PMID35360116
PMCPMC8963759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.